The Journal of Infectious Diseases under the title, "Early Appearance of Neutralizing Immunoglobulin G3 Antibodies Is Associated With Chikungunya Virus
Clearance and Long-term Clinical Protection" by Yiu-Wing Kam , Diane Simarmata , Angela Chow [2,3], Zhisheng Her [1,4], Terk-Shin Teng , Edward K.
aegypti or other mosquitoes species as vector transmitting chikungunya virus
at the studied localities.
Also, the chikungunya virus
was detected in Delhi alongside the dengue virus in 2006.
One of these diseases is caused by the Chikungunya virus
, which is transmitted by mosquitoes.
In 2015, the Centers for Disease Control and Prevention upgraded chikungunya virus
to a "nationally notifiable condition" in the United States, providing state and local health departments with standard definitions for reporting and tracking cases.
Viral culture may detect virus in the first three days of illness; however, chikungunya virus
should be handled under BSL 3 conditions.
A vaccine against the chikungunya virus
has proven protective in tests in monkeys, researchers reported.
The chikungunya virus
is insect- borne and is transmitted to humans by Aedes mosquitoes.
The outbreak occurred in 2006 appeared to be the more severe and one of the biggest outbreaks caused by chikungunya virus
(CHIKV) in India affecting over 13 lakh people (1,2).
Aedes aegypti, a mosquito that breeds in domestic and peri-domestic containers and an aggressive daytime biter is the primary vector of chikungunya virus
to humans in Asia (6).
DNA vaccine induces protective antibody and T-cell immune responses in non-human primates against Chikungunya virus
To the Editor: In the past 10 years, chikungunya virus
(CHIKV) has caused global epidemics of fever, rash, and arthralgia affecting millions of humans, most recently in the Americas (1).